Cumberland Pharmaceuticals Inc (CPIX) has a current Price-to-Book (P/B) ratio of 2.28. Compared to its 3-year average P/B ratio of 1.24, the current P/B ratio is approximately 83.48% higher. Relative to its 5-year average P/B ratio of 1.12, the current P/B ratio is about 102.72% higher. Cumberland Pharmaceuticals Inc (CPIX) has a Forward Free Cash Flow (FCF) yield of approximately 11.31%. Compared to its 3-year average FCF yield of 15.61%, the current FCF yield is approximately -27.52% lower. Relative to its 5-year average FCF yield of 15.04%, the current FCF yield is about -24.77% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for CPIX competitors is 0.13, providing a benchmark for relative valuation. Cumberland Pharmaceuticals Inc Corp (CPIX.O) exhibits a P/S ratio of 0.00, which is -100% above the industry average. Given its robust revenue growth of -8.73%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of CPIX increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of CPIX in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is CPIX currently overvalued or undervalued?

What is Cumberland Pharmaceuticals Inc (CPIX) fair value?

CPIX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Cumberland Pharmaceuticals Inc (CPIX) is between NaN to NaN according to relative valuation method.

How does CPIX's valuation metrics compare to the industry average?

The average P/S ratio for CPIX's competitors is 0.13, providing a benchmark for relative valuation. Cumberland Pharmaceuticals Inc Corp (CPIX) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of -8.73%, this premium appears unsustainable.

What is the current P/B ratio for Cumberland Pharmaceuticals Inc (CPIX) as of Mar 03 2026?

As of Mar 03 2026, Cumberland Pharmaceuticals Inc (CPIX) has a P/B ratio of 2.28. This indicates that the market values CPIX at 2.28 times its book value.

What is the current FCF Yield for Cumberland Pharmaceuticals Inc (CPIX) as of Mar 03 2026?

As of Mar 03 2026, Cumberland Pharmaceuticals Inc (CPIX) has a FCF Yield of 11.31%. This means that for every dollar of Cumberland Pharmaceuticals Inc's market capitalization, the company generates 11.31 cents in free cash flow.

What is the current Forward P/E ratio for Cumberland Pharmaceuticals Inc (CPIX) as of Mar 03 2026?

As of Mar 03 2026, Cumberland Pharmaceuticals Inc (CPIX) has a Forward P/E ratio of 0.00. This means the market is willing to pay $0.00 for every dollar of Cumberland Pharmaceuticals Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Cumberland Pharmaceuticals Inc (CPIX) as of Mar 03 2026?

As of Mar 03 2026, Cumberland Pharmaceuticals Inc (CPIX) has a Forward P/S ratio of 0.00. This means the market is valuing CPIX at $0.00 for every dollar of expected revenue over the next 12 months.

CPIX Valuation